Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From BioMetrics website
NOTE: Due to high demand and the need to fulfill existing orders, BioMedomics is temporarily halting new orders for COVID-19 tests. Our company will continue to fill all existing orders, and explore new ways to source materials and expand capacity to meet the growing demand for our tests. We are committed to doing our part to battle COVID-19.
FDA doesn't want at home tests
Still need FDA approval for the test.
Think it was by mistake since they took it down. Awaiting FDA approval - hopefully this week.
Think it was by mistake since they took it down. Awaiting FDA approval - hopefully this week.
They aren't going to sell or drop the stem cell business until they have other significant revenue streams.
With Birdman involved and the fact this is a company run by Russians I really don't believe anything they say until I see the numbers (results). Even then I not sure I will believe it. SEC can't prosecute someone in Russia for fraudulent financials.
I agree.
I seem to remember him saying the sold all his shares at a penny and a half years ago. No link though.
Something like this when the patient is expected to die what is there to lose. If I get the virus and having lung issues I certainly want them.
They aren't telling us yet because they don't want to alert their competitors. Even though its frustrating, gotta hang in there.
Is this the company that sold them $2M in stem cells they had to dispose of because they were contaminated?
Great move. How, your post stays here since it isn't on the PRED board!!
Fluff PR did more harm than good. Tell us when you have sales or a deal!
Thanks Brooklyn
The question is do they have the type of stem cells used to cure corona in China?
It's not a DNA type test
Now not before
Thanks for checking
Not necessarily shorts. Longs panic and capitulate and sell at/near bottom . "The world is ending". Human nature.
Please sell now and go away.
Yes, and no stem cell products from any company are FDA approved. Real shocker here - NOT.
$RAFA is the "STOCK OF MY LIFE" !!
says https://twitter.com/HotStocks_NYC a Pro Trader with 55 years #Trading Experience
WATCH [VIDEO] at 6.50 min Mark
Note that the shareholder letter doesn't contain the word "exclusive" anyway. Nice hype Birdman. One clinic and some other restaurants. Not exactly exclusive.
Good assessment. 100% agree.
I did. But only exclusive is with MTP; not the Thai government. Until I see it in the results, I really don't believe it.
I do not believe RAFA has any exclusive distribution at Thai medical clinics. It may have it at the detox clinics they are establishing with MTP but not the medical clinics; where the bulk of the sales will occur. I believe that certain people, especially someone with a bird, are greatly exaggerating this opportunity to get others into the stock. The stock price movement or rather the lack thereof seems to be confirming this.
Re-read that press release more carefully.
Don't make sense for company to announce anything positive with the current market backdrop.
Relax and have a Corona (virus) beer with a lime (lymes disease)!!!
Because retail (OTC) investors are clueless about Biotech.
Heard the same thing. Retail is very small percentage of float. It's just a matter of time before launch.
Company should be cash neutral this quarter with headcount cuts in the stem cell biz.
What big deal aside from the deal announced. You expecting BASF or something else?
TDA showing a .1006 close even though bid/ask is below .09
Valuation is based on the bigger number though. That's what counts.
Shares outstanding now 248M
How many shares does Merle still have?
At least we know that they are selling ArtGuide for (995). Slight mention of FertilityDX but no mention of EndoRisk. I;m wondering if EndoRisk is now in ArtGuide and no longer needed???? Anyone have any ideas on that?
Luckily market closed on Monday
Link to podcast
http://empoweredpatientradio.com/using-genetic-testing-to-advance-healthcare-for-women-with-brad-robinson-predictive-technology-group
I thought Artguide was $1,800 per January presentation